241 related articles for article (PubMed ID: 22328092)
1. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells.
Schuchardt M; Prüfer N; Tu Y; Herrmann J; Hu XP; Chebli S; Dahlke K; Zidek W; van der Giet M; Tölle M
Sci Rep; 2019 Mar; 9(1):3421. PubMed ID: 30833653
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
Chami B; Barrie N; Cai X; Wang X; Paul M; Morton-Chandra R; Sharland A; Dennis JM; Freedman SB; Witting PK
Int J Mol Sci; 2015 May; 16(5):11101-24. PubMed ID: 25988387
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.
Mao JY; Sun JT; Yang K; Shen WF; Lu L; Zhang RY; Tong X; Liu Y
J Diabetes Complications; 2017 Oct; 31(10):1538-1543. PubMed ID: 28760652
[TBL] [Abstract][Full Text] [Related]
5. The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein.
Witting PK; Song C; Hsu K; Hua S; Parry SN; Aran R; Geczy C; Freedman SB
Free Radic Biol Med; 2011 Oct; 51(7):1390-8. PubMed ID: 21784147
[TBL] [Abstract][Full Text] [Related]
6. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in ESRD: causes and potential consequences.
Kaysen GA; Kumar V
J Ren Nutr; 2003 Apr; 13(2):158-60. PubMed ID: 12671842
[TBL] [Abstract][Full Text] [Related]
8. Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells.
Martín-Ventura JL; Madrigal-Matute J; Muñoz-Garcia B; Blanco-Colio LM; Van Oostrom M; Zalba G; Fortuño A; Gomez-Guerrero C; Ortega L; Ortiz A; Diez J; Egido J
Cardiovasc Res; 2009 Aug; 83(3):586-94. PubMed ID: 19423618
[TBL] [Abstract][Full Text] [Related]
9. Activation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells.
Lee HY; Kim SD; Shim JW; Yun J; Kim K; Bae YS
Biochem Biophys Res Commun; 2009 Mar; 380(2):313-7. PubMed ID: 19167353
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.
Kisilevsky R; Subrahmanyan L
Lab Invest; 1992 Jun; 66(6):778-85. PubMed ID: 1602745
[TBL] [Abstract][Full Text] [Related]
11. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.
Prüfer N; Kleuser B; van der Giet M
Biol Chem; 2015 Jun; 396(6-7):573-83. PubMed ID: 25252751
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
14. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
15. PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs.
Dong Z; An F; Wu T; Zhang C; Zhang M; Zhang Y; An G; An F
J Cell Biochem; 2011 Aug; 112(8):2097-105. PubMed ID: 21465531
[TBL] [Abstract][Full Text] [Related]
16. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
Vaziri ND
J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
Gharavi NM; Gargalovic PS; Chang I; Araujo JA; Clark MJ; Szeto WL; Watson AD; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1346-53. PubMed ID: 17379837
[TBL] [Abstract][Full Text] [Related]
18. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
[TBL] [Abstract][Full Text] [Related]
19. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]